India moves closer to regulating prices of patented drugsBMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g1244 (Published 30 January 2014) Cite this as: BMJ 2014;348:g1244
- Meera Kay
The Indian government has come a step closer to making drugs more affordable and more widely available by establishing a committee to regulate the price of patented drugs.
The new committee is to meet early next month to discuss ways to reduce prices of patented drugs. The committee, comprising representatives of the Ministry of Commerce and Industry, Ministry of Health and Family Welfare, National Pharmaceutical Pricing Authority, and Department of Pharmaceuticals, was set up …
Log in using your username and password
Log in through your institution
Sign up for a free trial